Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
TX
|
Primary tumor cannot be assessed (e.g., shave biopsy or regressed melanoma)
|
|
T0
|
No evidence of primary tumor
|
|
Tis
|
Melanoma in situ
|
|
T1
|
Melanoma ≤1.0 mm in thickness, with or without ulceration
|
|
T1a
|
Melanoma ≤1.0 mm in thickness and level II or III, no ulceration
|
|
T1b
|
Melanoma ≤1.0 mm in thickness and level IV or V or with ulceration
|
|
T2
|
Melanoma 1.01-2.0 mm in thickness, with or without ulceration
|
|
T2a
|
Melanoma 1.01-2.0 mm in thickness, no ulceration
|
|
T2b
|
Melanoma 1.01-2.0 mm in thickness, with ulceration
|
|
T3
|
Melanoma 2.01-4.0 mm in thickness, with or without ulceration
|
|
T3a
|
Melanoma 2.01-4.0 mm in thickness, no ulceration
|
|
T3b
|
Melanoma 2.01-4.0 mm in thickness, with ulceration
|
|
T4
|
Melanoma >4.0 mm in thickness, with or without ulceration
|
|
T4a
|
Melanoma >4.0 mm in thickness, no ulceration
|
|
T4b
|
Melanoma >4.0 mm in thickness, with ulceration
|
|
NX
|
Regional lymph nodes cannot be assessed
|
|
N0
|
No regional lymph node metastasis
|
|
N1
|
Metastasis in one lymph node
|
|
N1a
|
Clinically occult (microscopic) metastasis
|
|
N1b
|
Clinically apparent (macroscopic) metastasis
|
|
N2
|
Metastasis in two or three regional nodes or intralymphatic regional metastasis without nodal metastases
|
|
N2a
|
Clinically occult (microscopic) metastasis
|
|
N2b
|
Clinically apparent (macroscopic) metastasis
|
|
N2c
|
Satellite or in-transit metastasis without nodal metastasis
|
|
N3
|
Metastasis in four or more regional nodes, matted metastatic nodes, in-transit metastasis, or satellites with metastasis in regional node(s)
|
|
MX
|
Distant metastasis cannot be assessed
|
|
M0
|
No distant metastasis
|
|
M1
|
Distant metastasis
|
|
M1a
|
Metastasis to skin, subcutaneous tissue, or distant lymph nodes
|
|
M1b
|
Metastasis to lung
|
|
M1c
|
Metastasis to all other visceral sites or distant metastasis at any site associated with elevated serum lactate dehydrogenase
|
|
Pathologic stage 0
|
TNM Grouping Tis N0 M0
|
|
Pathologic stage IA
|
TNM Grouping T1a N0 M0
|
|
Pathologic stage IB
|
TNM Grouping T1b N0 M0; T2a N0 M0
|
|
Pathologic stage IIA
|
TNM Grouping T2b N0 M0;
T3a N0 M0 |
|
Pathologic stage IIB
|
TNM Grouping T3b N0 M0;
T4a N0 M0 |
|
Pathologic stage IIC
|
TNM Grouping T4b N0 M0
|
|
Pathologic stage IIIA
|
TNM Grouping T1-4a N1a M0; T1-4a N2a M0
|
|
Pathologic stage IIIB
|
TNM Grouping T1-4b N1a M0;
T1-4b N2a M0; T1-4a N1b M0; T1-4a N2b M0; T1-4a/b N2c M0 |
|
Pathologic stage IIIC
|
TNM Grouping T1-4b N1b M0;
T1-4b N2b M0; Any T N3 M0 |
|
Pathologic stage IV
|
TNM Grouping: Any T Any N M1
|